Read More

Psyched: Australia’s Innovative Program, Congressional Amendments, Therapy Reimbursement And More

First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic stress disorder (PTSD) and psilocybin to combat treatment-resistant depression.

AWKNF

Read More

Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Inju…

Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)))) today announced that Company's abstract, titled: "MEG Source Imaging Reveals Neuronal Changes in

NXL